Roche & reMYND enter into a strategic alliance to develop disease-modifying treatments for Parkinson’s and Alzheimer’s: http://tiny.cc/vgsr5
posted 9 hours ago
FlandersBio informs you about important regional and national life sciences news. Send us your news. If your news is of interest to the life sciences community, we will post it on our website.
Gimv volgt kapitaalronde biotechbedrijf Ceres (volledig artikel enkel beschikbaar voor abonnees van De Tijd)
Source: De Tijd
Tags: financing